Positron Emission Tomography (PET) Images Using Deep Neural Networks

NCT ID: NCT04140565

Last Updated: 2019-10-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-01

Study Completion Date

2021-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PET images are based on detecting two annihilation 511 KeV photons that are produced by positron emitting isotopes. The longer the acquisition time, the more photons are detected and processed, resulting in better image quality. However, long scan times (typically 20-40 minutes per scan) are less convenient to patients, and may result in patient motion and misalignment.

several studies have used machine learning to produce diagnostic images from low quality images.The goal of our study is to produce diagnostic PET images with 10 seconds acquisition time per bed position using DNN algorithms

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Positron emission tomography (PET)/ computerized tomography (CT), with the use of several tracers, among which fluoro deoxyglucose (FDG) is the most prevalent, has become a principal imaging modality in oncology. The PET and CT components reflect metabolic and anatomic information, respectively. PET images are based on detecting two annihilation 511 KeV photons that are produced by positron emitting isotopes. The longer the acquisition time, the more photons are detected and processed, resulting in better image quality. However, long scan times (typically 20-40 minutes per scan) are less convenient to patients, and may result in patient motion and misalignment. Over the years, several methods, such as 3D and time of flight acquisitions, have been developed to compensate for the degradation in image quality as a result of shortening of the scanning time. Recently, several studies have used machine learning to produce diagnostic images from low quality images. Xiang et al compared PET images of the brain that were acquired in 3 minutes (i.e., low-quality PET (LPET)) with standard PET images (i.e., SPET) that were acquired in 12 minutes. They have combined LPET and T1 weighted images using deep neural networks (DNN) to produce diagnostic PET images equivalent to SPET images.

The goal of our study is to produce diagnostic PET images with 10 seconds acquisition time per bed position using DNN algorithms developed at the CILAB laboratory in the imaging department of Sheba.

The algorithms were previously successfully validated for the denoising of ultra-low dose chest CT scans, making them suitable for lung cancer screening. The algorithms are based on the locally-consistent non-local means (LC-NLM) algorithm.

The LC-NLM algorithm uses fast approximate nearest neighbors (ANN) to find the most similar high-SNR patch, in a purposely built database, for each noisy patch in the input image (Green et al.) \] We propose to use the recently introduced non-local neural networks (Wang et al.) in order to stack the LC-NLM into a fully trainable, locally-consistent nonlocal block (LC-NLB). The original non-local networks combines the ideas of the classical non-local means (NLM) algorithm (Buades et al.) into a neural network block, which computes the output at a specific position as a weighted sum of the features at all positions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PET Images and Deep Neural Networks Algorithms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Computational Imaging Lab , Dr. Arnaldo Mayer

UNKNOWN

Sponsor Role collaborator

Sheba Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Liran Domachevsky

Chair, Department of Nuclear Medicine Sheba Medical Center

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Liran Domachevsky, MD

Role: PRINCIPAL_INVESTIGATOR

Sheba Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sheba Medical Center Hospital- Tel Hashomer

Ramat Gan, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Liran Domachevsky, MD

Role: CONTACT

972-53-3387635

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liran Domachevsky, MD

Role: primary

052-53-3387635

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHEBA-19-6267-LD-CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Radionecrosis and FDG PET
NCT02391246 UNKNOWN